LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 47

Search options

  1. Article ; Online: Pedunculated jejunal vascular malformation: a rare cause of abdominal pain.

    Daley, Michael / Lonne, Michael / Yuide, Peter

    ANZ journal of surgery

    2022  Volume 92, Issue 10, Page(s) 2742–2743

    MeSH term(s) Abdominal Pain/diagnosis ; Abdominal Pain/etiology ; Humans ; Jejunal Diseases/complications ; Jejunal Diseases/diagnosis ; Jejunal Diseases/surgery ; Jejunum/surgery ; Vascular Malformations/complications ; Vascular Malformations/diagnosis
    Language English
    Publishing date 2022-03-01
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 2050749-5
    ISSN 1445-2197 ; 1445-1433 ; 0004-8682
    ISSN (online) 1445-2197
    ISSN 1445-1433 ; 0004-8682
    DOI 10.1111/ans.17585
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The optimal Fontan operation: Lateral tunnel or extracardiac conduit?

    Daley, Michael / d'Udekem, Yves

    The Journal of thoracic and cardiovascular surgery

    2020  Volume 162, Issue 6, Page(s) 1825–1834

    MeSH term(s) Fontan Procedure/methods ; Humans ; Treatment Outcome
    Language English
    Publishing date 2020-12-28
    Publishing country United States
    Document type Editorial ; Review
    ZDB-ID 3104-5
    ISSN 1097-685X ; 0022-5223
    ISSN (online) 1097-685X
    ISSN 0022-5223
    DOI 10.1016/j.jtcvs.2020.11.179
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: In patients undergoing Fontan completion, does a younger age at operation result in better long-term exercise capacity and prognosis?

    Daley, Michael / d'Udekem, Yves

    Interactive cardiovascular and thoracic surgery

    2018  Volume 28, Issue 2, Page(s) 301–305

    Abstract: A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'In [patients undergoing Fontan completion], does [a younger age at operation] result in [better long-term exercise capacity and prognosis] ...

    Abstract A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'In [patients undergoing Fontan completion], does [a younger age at operation] result in [better long-term exercise capacity and prognosis]?'. Altogether, 304 papers were found using the reported search, of which 10 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Of these, 2 recent large reviews describe a better or a non-significant trend towards better outcomes when the Fontan procedure is performed at a younger age. This is supported by 4 studies demonstrating better long-term exercise capacity when patients undergo Fontan completion at a younger age. Additionally, 2 other studies describe increased rates of failure, adverse events and arrhythmias with older age at Fontan completion. Two publications describe non-inferior outcomes in patients with an older age at Fontan completion, although limited by the number of patients and follow-up. We conclude that the Fontan operation should be performed at an early age (<7 years) because the data show higher survival and fewer adverse events, and the gradual decline in exercise capacity in Fontan patients appears accelerated when the Fontan operation is performed at older age.
    MeSH term(s) Adult ; Age Factors ; Child ; Child, Preschool ; Exercise Tolerance ; Female ; Fontan Procedure ; Heart Defects, Congenital/mortality ; Heart Defects, Congenital/physiopathology ; Heart Defects, Congenital/surgery ; Humans ; Male ; Prognosis ; Treatment Outcome
    Language English
    Publishing date 2018-08-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2095298-3
    ISSN 1569-9285 ; 1569-9293
    ISSN (online) 1569-9285
    ISSN 1569-9293
    DOI 10.1093/icvts/ivy219
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Consequences on Private Insurance Coverage: The AAOS Clinical Practice Guidelines and Hyaluronic Acid Injections.

    Vangsness, C Thomas / Adamson, Thomas C / Daley, Michael J

    The Journal of bone and joint surgery. American volume

    2020  Volume 102, Issue 10, Page(s) 920–926

    MeSH term(s) Humans ; Hyaluronic Acid/administration & dosage ; Injections ; Insurance Coverage/statistics & numerical data ; Insurance, Health/economics ; Medicare/economics ; Osteoarthritis, Knee/drug therapy ; United States
    Chemical Substances Hyaluronic Acid (9004-61-9)
    Language English
    Publishing date 2020-02-20
    Publishing country United States
    Document type Journal Article ; Practice Guideline
    ZDB-ID 220625-0
    ISSN 1535-1386 ; 0021-9355
    ISSN (online) 1535-1386
    ISSN 0021-9355
    DOI 10.2106/JBJS.19.00272
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Evaluation of the Precision of Kinetic Stem Cell (KSC) Counting for Specific Quantification of Human Mesenchymal Stem Cells in Heterogeneous Tissue Cell Preparations.

    Chopra, Hitesh / Daley, Michael P / Kumar, Adhya / Sugai, James / Dahlkemper, Alex / Kaigler, Darnell / Sherley, James L

    Life (Basel, Switzerland)

    2023  Volume 14, Issue 1

    Abstract: Kinetic stem cell (KSC) counting is a recently introduced first technology for quantifying tissue stem cells in vertebrate organ and tissue cell preparations. Previously, effective quantification of the fraction or dosage of tissue stem cells had been ... ...

    Abstract Kinetic stem cell (KSC) counting is a recently introduced first technology for quantifying tissue stem cells in vertebrate organ and tissue cell preparations. Previously, effective quantification of the fraction or dosage of tissue stem cells had been largely lacking in stem cell science and medicine. A general method for the quantification of tissue stem cells will accelerate progress in both of these disciplines as well as related industries like drug development. Triplicate samples of human oral alveolar bone cell preparations, which contain mesenchymal stem cells (MSCs), were used to estimate the precision of KSC counting analyses conducted at three independent sites. A high degree of intra-site precision was found, with coefficients of variation for determinations of MSC-specific fractions of 8.9% (
    Language English
    Publishing date 2023-12-28
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life14010051
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Noel Warner Ph.D.

    Preffer, Frederic / Dunne, Jack / Recktenwald, Diether / Blidy, Andrew / Lanier, Lewis / Trotter, Joe / Daley, Michael J

    Cytometry. Part B, Clinical cytometry

    2023  Volume 104, Issue 1, Page(s) 7–9

    MeSH term(s) Humans ; Flow Cytometry
    Language English
    Publishing date 2023-01-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2099657-3
    ISSN 1552-4957 ; 1552-4949 ; 0196-4763
    ISSN (online) 1552-4957
    ISSN 1552-4949 ; 0196-4763
    DOI 10.1002/cyto.b.22112
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Implementation of Patient Blood Management in Orthotopic Heart Transplants: A Single Centre Retrospective Observational Review.

    Rapier, Jacob J / Daley, Michael / Smith, Susan E / Goh, Sean L / Margale, Swaroop / Smith, Ian / Thomson, Bruce M / Tesar, Peter J / Pearse, Bronwyn L

    Heart, lung & circulation

    2024  Volume 33, Issue 4, Page(s) 518–523

    Abstract: Background: Blood transfusion in the perioperative cardiothoracic setting has accepted risks including deep sternal wound infection, increased intensive care unit length of stay, lung injury, and cost. It has an immunomodulatory effect which may cause ... ...

    Abstract Background: Blood transfusion in the perioperative cardiothoracic setting has accepted risks including deep sternal wound infection, increased intensive care unit length of stay, lung injury, and cost. It has an immunomodulatory effect which may cause allo-immunisation. This may influence long-term survival through immune-mediated factors. Targeting coagulation defects to reduce unnecessary or inappropriate transfusions may reduce these complications.
    Methods: In 2012, an institution-wide patient blood management evidence-based algorithmic bleeding management protocol was implemented at The Prince Charles Hospital, Brisbane, Australia. The benefit of this has been previously reported in our lung transplant and cardiac surgery (excluding transplants) cohorts. This study aimed to investigate the effect of this on our orthotopic heart transplant recipients.
    Results: After the implementation of the protocol, despite no difference in preoperative haemoglobin levels and higher risk patients (EuroSCORE 20 vs 26; p=0.013), the use of packed red blood cells (13.0 U vs 4.4 U; p=0.046) was significantly lower postoperatively and fresh frozen plasma was significantly lower both intra- and postoperatively (7.4 U vs 0.6 U; p<0.001, and 3.3 U vs 0.6 U; p=0.011 respectively). Concurrently, the use of prothrombin complex concentrate (33% vs 78%; p<0.001) and desmopressin (5% vs 22%; p=0.0028) was significantly higher in the post-protocol group, while there was less use of recombinant factor VIIa (15% vs 4%; p=0.058). Intraoperative units of cryoprecipitate also rose from 0.9 to 2.0 (p=0.006).
    Conclusions: We have demonstrated that a targeted patient blood management protocol with point-of-care testing for heart transplant recipients is correlated with fewer blood products used postoperatively, with some increase in haemostatic products and no evidence of increased adverse events.
    MeSH term(s) Humans ; Heart Transplantation/adverse effects ; Retrospective Studies ; Female ; Male ; Middle Aged ; Blood Transfusion/statistics & numerical data ; Blood Transfusion/methods ; Blood Coagulation Factors/therapeutic use ; Aged ; Adult
    Chemical Substances Blood Coagulation Factors
    Language English
    Publishing date 2024-02-15
    Publishing country Australia
    Document type Journal Article ; Observational Study
    ZDB-ID 2020980-0
    ISSN 1444-2892 ; 1443-9506
    ISSN (online) 1444-2892
    ISSN 1443-9506
    DOI 10.1016/j.hlc.2024.01.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Missing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain.

    Altman, Roy D / Ike, Robert W / Hamburger, Max I / McLain, David A / Daley, Michael J / Adamson, Thomas C

    The Journal of rheumatology

    2022  Volume 49, Issue 8, Page(s) 958–960

    MeSH term(s) Humans ; Hyaluronic Acid/therapeutic use ; Injections, Intra-Articular ; Osteoarthritis/drug therapy ; Osteoarthritis, Knee/drug therapy ; Pain ; Rheumatology ; Treatment Outcome
    Chemical Substances Hyaluronic Acid (9004-61-9)
    Language English
    Publishing date 2022-07-25
    Publishing country Canada
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 194928-7
    ISSN 1499-2752 ; 0315-162X
    ISSN (online) 1499-2752
    ISSN 0315-162X
    DOI 10.3899/jrheum.220125
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Impact of Aortic Atresia After Fontan Operation in Patients With Hypoplastic Left Heart Syndrome.

    King, Gregory / Buratto, Edward / Daley, Michael / Iyengar, Ajay / Alphonso, Nelson / Grigg, Leeanne / Cordina, Rachael / d'Udekem, Yves / Konstantinov, Igor E

    The Annals of thoracic surgery

    2022  Volume 116, Issue 1, Page(s) 95–102

    Abstract: Background: Patients with aortic atresia have the worst prognosis in the spectrum of hypoplastic left heart syndrome. It remains unknown whether patients with aortic atresia continue to do poorly after Fontan operation. This study aimed to determine the ...

    Abstract Background: Patients with aortic atresia have the worst prognosis in the spectrum of hypoplastic left heart syndrome. It remains unknown whether patients with aortic atresia continue to do poorly after Fontan operation. This study aimed to determine the association between aortic atresia and atrioventricular valve (AVV) function and clinical outcomes after Fontan operation in patients with hypoplastic left heart syndrome.
    Methods: We performed a retrospective study of 1731 patients who survived the Fontan operation from the Australia and New Zealand Fontan Registry between 1975 and 2020.
    Results: We identified 188 patients with hypoplastic left heart syndrome, including 99 (53%) with aortic atresia. Overall transplant-free survival and freedom from failure of Fontan circulation at 15 years was 91% (95% CI, 86%-96%) and 79% (95% CI, 71%-88%), respectively. The cumulative incidence of AVV operation at 15 years of age for patients with aortic atresia and aortic stenosis was 28% (95% CI, 19%-38%) and 14% (95% CI, 7%-22%; P = .03), respectively. The cumulative incidence of AVV failure (moderate or greater regurgitation or AVV operation) at 15 years of age for patients with aortic atresia and aortic stenosis was 50% (95% CI, 37%-61%) and 30% (95% CI, 19%-42%; P = .01). Patients with AVV failure were at increased risk of having moderately, or worse, decreased systolic ventricular function (odds ratio 6.7; 95% CI, 1.7-33; P = .01) and failure of Fontan circulation (hazard ratio 3.7; 95% CI, 1.5-9.1; P < .01).
    Conclusions: In patients with hypoplastic left heart syndrome, there is no significant difference in transplant-free survival after Fontan operation between patients with aortic atresia and patients with aortic stenosis. However, patients with aortic atresia have a much higher burden of AVV failure than patients with aortic stenosis. Atrioventricular valve failure is associated with failure of Fontan circulation.
    MeSH term(s) Humans ; Fontan Procedure ; Hypoplastic Left Heart Syndrome/surgery ; Retrospective Studies ; Aortic Valve Stenosis ; Aortic Diseases ; Treatment Outcome
    Language English
    Publishing date 2022-09-21
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 211007-6
    ISSN 1552-6259 ; 0003-4975
    ISSN (online) 1552-6259
    ISSN 0003-4975
    DOI 10.1016/j.athoracsur.2022.09.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: CardioCel® for repair of congenital heart defects: nationwide results of over 1000 implants.

    Patukale, Aditya A / Marathe, Supreet P / Betts, Kim S / Daley, Michael / Shetty, Gautham / Anand, Abhishek / Suna, Jessica / Andrews, David / Karl, Tom R / Brizard, Christian / Venugopal, Prem / Alphonso, Nelson

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

    2023  Volume 64, Issue 4

    Abstract: Objectives: To assess the mid-term performance of CardioCel for the repair of congenital heart defects.: Methods: Data were retrospectively collected from databases and hospital records in 3 congenital cardiac surgery centres in Australia. Kaplan- ... ...

    Abstract Objectives: To assess the mid-term performance of CardioCel for the repair of congenital heart defects.
    Methods: Data were retrospectively collected from databases and hospital records in 3 congenital cardiac surgery centres in Australia. Kaplan-Meier curves and log-rank tests were used to test for associations between patient age, gender, patch type and site of implantation. Multivariable Cox regression was used to test whether any specific implantation site was associated with reintervention risk, after adjusting for age group, gender and patch type.
    Results: A total of 1184 CardioCel patches were implanted in 752 patients under the age of 18 years. Median age at implant was 12 months [interquartile range (IQR) 3.6-84]. Median follow-up was 2.1 years (IQR 0.6-4.6). Probability of freedom from CardioCel-related reintervention was 93% [95% confidence interval (CI) 91-95] at 1 year, 91% (95% CI 88-93) at 3 years and 88% (95% CI 85-91) at 5 years, respectively. On multivariable regression analysis, aortic valve repair had a higher incidence of reintervention [hazard ratio (HR) = 7.15, P = 0.008] compared to other sites. The probability of reintervention was higher in neonates (HR = 6.71, P = 0.0007), especially when used for augmentation of the pulmonary arteries (HR = 14.38, P = 0.029), as compared to other age groups.
    Conclusions: CardioCel can be used for the repair of a variety of congenital heart defects. In our study, in patients receiving a CardioCel implant, reinterventions were higher when CardioCel was used to augment the pulmonary arteries in neonates and for aortic valve repair as compared to other sites.
    MeSH term(s) Infant, Newborn ; Humans ; Infant ; Adolescent ; Tissue Engineering/methods ; Retrospective Studies ; Heart Defects, Congenital/epidemiology ; Heart Defects, Congenital/surgery ; Prostheses and Implants ; Cardiac Surgical Procedures/methods ; Treatment Outcome
    Language English
    Publishing date 2023-10-16
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 639293-3
    ISSN 1873-734X ; 1010-7940 ; 1567-4258
    ISSN (online) 1873-734X
    ISSN 1010-7940 ; 1567-4258
    DOI 10.1093/ejcts/ezad343
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top